SCHEMBL16686997

SCHEMBL16686997

ON=Cc1ccc2occ(C(F)(F)F)c2c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NPFFR1 Q9GZQ6 2/20 0.35
NPFFR2 Q9Y5X5 2/20 0.35
HTT P42858 2/20 0.34
POLB P06746 1/20 0.34
PKM P14618 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16686996 1.00 ALDH1A1 (0.40) ALDH1A1KDM4EL3MBTL1NPFFR1NPFFR2
SCHEMBL16684607 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1HTTPOLB
SCHEMBL16684604 0.80 CYP2A6 (0.42) ALDH1A1KDM4EPOLBCA12CA1
SCHEMBL16693146 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1HTTPOLB
SCHEMBL16684606 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EL3MBTL1HTTPOLB
SCHEMBL16684707 0.76 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1HTTPOLB
SCHEMBL16684706 0.76 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1HTTPOLB
SCHEMBL23241583 0.70 TP53 (0.46) ALDH1A1CA12CA1CA2CA9
SCHEMBL2447368 0.70 NPFFR1 (0.43) ALDH1A1KDM4EL3MBTL1NPFFR1NPFFR2
SCHEMBL2447369 0.70 NPFFR1 (0.43) ALDH1A1KDM4EL3MBTL1NPFFR1NPFFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066371-A1 SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2015-05-07 WO disclosed